tiprankstipranks
Trending News
More News >
Luye Pharma Group Ltd. (LYPHF)
OTHER OTC:LYPHF
US Market

Luye Pharma Group (LYPHF) Ratios

Compare
3 Followers

Luye Pharma Group Ratios

LYPHF's free cash flow for Q4 2024 was ¥0.66. For the 2024 fiscal year, LYPHF's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.32 1.32 1.14 1.42 1.38
Quick Ratio
1.21 1.21 1.06 1.32 1.29
Cash Ratio
0.40 0.40 0.24 0.33 0.53
Solvency Ratio
0.10 0.10 0.10 0.03 0.10
Operating Cash Flow Ratio
0.20 0.20 0.17 0.02 0.14
Short-Term Operating Cash Flow Coverage
0.31 0.31 0.24 0.03 0.18
Net Current Asset Value
¥ -550.42M¥ -1.26B¥ -2.42B¥ -3.07B¥ -2.56B
Leverage Ratios
Debt-to-Assets Ratio
0.33 0.33 0.38 0.42 0.48
Debt-to-Equity Ratio
0.67 0.67 0.89 1.12 1.26
Debt-to-Capital Ratio
0.40 0.40 0.47 0.53 0.56
Long-Term Debt-to-Capital Ratio
0.20 0.20 0.18 0.33 0.35
Financial Leverage Ratio
2.03 2.03 2.38 2.66 2.61
Debt Service Coverage Ratio
0.33 0.33 0.24 0.15 0.27
Interest Coverage Ratio
1.31 1.31 2.58 0.97 3.35
Debt to Market Cap
0.66 0.66 0.81 0.95 1.03
Interest Debt Per Share
2.44 2.44 2.75 2.87 3.26
Net Debt to EBITDA
3.00 2.50 3.74 7.78 3.26
Profitability Margins
Gross Profit Margin
68.44%68.44%69.22%65.32%72.04%
EBIT Margin
22.39%22.39%19.08%6.25%24.66%
EBITDA Margin
33.82%33.82%30.31%17.44%33.88%
Operating Profit Margin
14.45%14.45%20.31%7.44%25.61%
Pretax Profit Margin
11.40%11.40%11.20%-1.43%17.01%
Net Profit Margin
8.67%8.67%10.11%-2.78%12.76%
Continuous Operations Profit Margin
8.78%8.78%9.75%-2.78%12.70%
Net Income Per EBT
76.08%76.08%90.30%194.19%75.00%
EBT Per EBIT
78.89%78.89%55.13%-19.27%66.40%
Return on Assets (ROA)
1.59%2.09%2.49%-0.64%3.42%
Return on Equity (ROE)
3.33%4.25%5.94%-1.71%8.95%
Return on Capital Employed (ROCE)
6.09%5.11%8.23%2.54%10.59%
Return on Invested Capital (ROIC)
3.34%3.03%4.90%3.66%5.56%
Return on Tangible Assets
2.14%2.71%3.50%-0.90%4.77%
Earnings Yield
6.16%4.23%5.38%-1.45%7.34%
Efficiency Ratios
Receivables Turnover
2.61 2.61 3.35 2.95 3.57
Payables Turnover
2.53 2.53 3.29 3.16 3.19
Inventory Turnover
2.34 2.34 2.38 2.42 2.53
Fixed Asset Turnover
1.20 1.20 1.22 1.13 1.28
Asset Turnover
0.24 0.24 0.25 0.23 0.27
Working Capital Turnover Ratio
3.18 3.18 2.74 1.79 1.69
Cash Conversion Cycle
299.25 151.34 151.07 159.40 132.27
Days of Sales Outstanding
258.97 139.92 108.84 123.89 102.33
Days of Inventory Outstanding
165.00 155.85 153.23 151.05 144.28
Days of Payables Outstanding
124.72 144.42 111.01 115.54 114.34
Operating Cycle
423.97 295.77 262.07 274.94 246.61
Cash Flow Ratios
Operating Cash Flow Per Share
0.43 0.43 0.48 0.05 0.32
Free Cash Flow Per Share
0.12 0.12 0.14 -0.39 -0.15
CapEx Per Share
0.31 0.31 0.33 0.45 0.48
Free Cash Flow to Operating Cash Flow
0.27 0.27 0.30 -7.45 -0.47
Dividend Paid and CapEx Coverage Ratio
1.37 1.37 1.42 0.12 0.61
Capital Expenditure Coverage Ratio
1.37 1.37 1.42 0.12 0.68
Operating Cash Flow Coverage Ratio
0.19 0.19 0.18 0.02 0.10
Operating Cash Flow to Sales Ratio
0.26 0.26 0.28 0.04 0.19
Free Cash Flow Yield
0.00%3.41%4.36%-13.61%-5.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.66 23.66 18.60 -68.99 13.62
Price-to-Sales (P/S) Ratio
2.05 2.05 1.88 1.92 1.74
Price-to-Book (P/B) Ratio
1.01 1.01 1.11 1.18 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
29.29 29.29 22.95 -7.35 -19.79
Price-to-Operating Cash Flow Ratio
7.90 7.90 6.80 54.77 9.31
Price-to-Earnings Growth (PEG) Ratio
-1.34 -1.34 -0.04 0.58 -0.26
Price-to-Fair Value
1.01 1.01 1.11 1.18 1.22
Enterprise Value Multiple
8.56 8.56 9.95 18.79 8.39
Enterprise Value
13.05B 17.79B 18.03B 17.04B 15.74B
EV to EBITDA
7.28 8.56 9.95 18.79 8.39
EV to Sales
2.15 2.90 3.01 3.28 2.84
EV to Free Cash Flow
0.00 41.34 36.79 -12.54 -32.36
EV to Operating Cash Flow
0.00 11.15 10.90 93.45 15.23
Tangible Book Value Per Share
2.06 2.06 1.16 0.78 0.71
Shareholders’ Equity Per Share
3.36 3.36 2.92 2.46 2.48
Tax and Other Ratios
Effective Tax Rate
0.23 0.23 0.13 -0.94 0.25
Revenue Per Share
1.65 1.65 1.72 1.51 1.74
Net Income Per Share
0.14 0.14 0.17 -0.04 0.22
Tax Burden
0.56 0.76 0.90 1.94 0.75
Interest Burden
0.74 0.51 0.59 -0.23 0.69
Research & Development to Revenue
0.08 0.10 0.14 0.13 0.14
SG&A to Revenue
0.10 0.10 0.10 0.11 0.09
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.00 2.28 2.47 -2.45 1.10
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis